353
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Role of IL-1ra and Granzyme B as biomarkers in active Crohn’s disease patients

, , , , , & show all
Pages 161-166 | Received 07 Apr 2017, Accepted 01 Oct 2017, Published online: 16 Oct 2017

References

  • Arend, W.P., and Guthridge, C.J., 2000. Biological role of interleukin 1 receptor antagonist isoforms. Annals of the rheumatic diseases, 59(Suppl1), i60–i64.
  • Casini-Raggi, V., et al., 1995. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. Journal of immunology, 154, 2434–2440.
  • Florholmen, J., and Fries, W., 2011. Candidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology. Scandinavian journal of gastroenterology, 46, 1407–1417.
  • Hyams, J.S., et al., 1994. Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease. Digestive diseases and sciences, 39, 1893–1899.
  • Iida, N., and Grotendorst, G.R., 1990. Cloning and sequencing of a new gro transcript from activated human monocytes: expression in leukocytes and wound tissue. Molecular and cellular biology, 10, 5596–5599.
  • Jenkins, D., et al., 2000. Differential levels of Granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation. Journal of pathology, 190, 184–189.
  • Kaser, A., Zeissig, S., and Blumberg, R.S., 2010. Inflammatory bowel disease. Annual review of immunology, 28, 573–621.
  • Leal, R.F., et al., 2015. Identification of inflammatory mediators in patients with Crohn’s disease unresponsive to anti-TNFalpha therapy. Gut, 64, 233–242.
  • Loukinova, E., et al., 2000. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene, 19, 3477–3486.
  • Merger, M., et al., 2002. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine. Gut, 51, 155–163.
  • Mitsuyama, K., et al., 2006. Increased circulating concentrations of growth-related oncogene (GRO)-alpha in patients with inflammatory bowel disease. Digestive diseases and sciences, 51, 173–177.
  • Mittal, R.D., Bid, H.K., and Ghoshal, U.C., 2005. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India. Scandinavian journal of gastroenterology, 40, 827–831.
  • Nakamura, M., et al., 1992. Cytokine production in patients with inflammatory bowel disease. Gut, 33, 933–937.
  • Nathan, C., 2006. Neutrophils and immunity: challenges and opportunities. Nature reviews immunology, 6, 173–182.
  • Neuman, M.G., 2007. Immune dysfunction in inflammatory bowel disease. Translational research, 149, 173–186.
  • Neurath, M.F., 2014. Cytokines in inflammatory bowel disease. Nature reviews immunology, 14, 329–342.
  • Strober, W., Fuss, I., and Mannon, P., 2007. The fundamental basis of inflammatory bowel disease. Journal of clinical investigation, 117, 514–521.
  • Tountas, N.A., et al., 1999. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology, 117, 806–813.
  • Velikova, T., et al., 2017. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens. Cytokine, 92, 12–19.
  • Ye, B.D., et al., 2009. Diagnostic guideline of Crohn’s disease. Korean journal of gastroenterology, 53, 161–176.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.